GONZALO CECILIA 4
4 · Talon Therapeutics, Inc. · Filed Jul 3, 2012
Insider Transaction Report
Form 4
GONZALO CECILIA
Director
Transactions
- Conversion
Series A-3 Convertible Preferred Stock, $0.001 Par Value
2012-07-03$100.00/sh+27,000$2,700,000→ 27,000 total(indirect: See footnotes)Exercise: $0.35From: 2012-07-03→ Common Stock (7,714,285 underlying) - Conversion
Right to Acquire Series A-3 Convertible Preferred Stock
2012-07-03−27,000→ 570,000 total(indirect: See footnotes)Exercise: $100.00From: 2012-01-09→ Series A-3 Conv. Pref. Stock, $0.001 Par Value (27,000 underlying)
Footnotes (4)
- [F1]See Exhibit 99.1, Note 1.
- [F2]See Exhibit 99.1, Note 2.
- [F3]See Exhibit 99.1, Note 3.
- [F4]See Exhibit 99.1, Note 4.